TGFB1 and prostate carcinoma: In prostate cancer, there is a dramatic increase in TGF-β1 mRNA and protein levels, which are correlated with high Gleason score, bone metastasis, angiogenesis and poor clinical outcome 27,78 (Fig. 2).